The Pharma Letter: Drugmakers and middlemen fight over who’s to blame for high US prices

The Pharma Letter: Drugmakers and middlemen fight over who’s to blame for high US prices

PCMA said that the evidence showed drugmakers determine list prices independently of any rebates they negotiate with PBMs